z-logo
open-access-imgOpen Access
A new perspective on the pleiotropic blood pressure improvement effect of sitagliptin: downregulation of miRNA-155 and miRNA-21
Author(s) -
M Yilmaz-Bozoglan K Gul-Kahraman,
I Serhatlioglu,
Erhan Önalan,
M C Akkopru,
Engin Şahna
Publication year - 2021
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2021_145
Subject(s) - sitagliptin , blood pressure , medicine , endocrinology , microrna , asymmetric dimethylarginine , type 2 diabetes mellitus , glycemic , diabetes mellitus , pharmacology , chemistry , arginine , biochemistry , amino acid , gene
Deterioration of vascular responses is the crucial event in the initiation of cardiovascular problems in hypertension (HT) and diabetes mellitus (DM). A well-known oral antidiabetic, sitagliptin, has pleiotropic effects besides improving glycemic state in type-2 DM. This study aimed to investigate the therapeutic effect of sitagliptin on blood pressure with previously unassessed parameters of well-known pathophysiological processes and especially at the microRNA (miRNA) level where there are many unknowns.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here